Paper41335159
Engineering Mesenchymal Stem Cell-Derived Extracellular Vesicles for the Treatment of Chronic Kidney Diseases.
Liao HJ and 3 others. Tissue Eng Regen Med, 2026. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. Engineering Mesenchymal Stem Cell-Derived Extracellular Vesicles for the Treatment of Chronic Kidney Diseases. Papers, record 41335159. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41335159
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Engineering Mesenchymal Stem Cell-Derived Extracellular Vesicles for the Treatment of Chronic Kidney Diseases.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Mesenchymal Stem Cells | Major topic |
| Extracellular Vesicles | Major topic |
| Renal Insufficiency, Chronic | Major topic |
| Tissue Engineering | Major topic |
| Mesenchymal Stem Cell Transplantation | Major topic |
| Humans | |
| Animals | |
| Exosomes | |
| Regenerative Medicine |
Source PubMed
Grants12
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| MOST 111-2314-B-418-004 | Ministry of Science and Technology, Taiwan | PubMed | ||
| MOST 111-2321-B-418-002- | Ministry of Science and Technology, Taiwan | PubMed | ||
| MOST 111-2314-B-418-003- | Ministry of Science and Technology, Taiwan | PubMed | ||
| NSTC 112-2321-B-418-004- | Ministry of Science and Technology, Taiwan | PubMed | ||
| NSTC 112-2314-B-418-010-MY3 | Ministry of Science and Technology, Taiwan | PubMed | ||
| 2022-C-042 | Far Eastern Memorial Hospital | PubMed | ||
| 2022-C-123 | Far Eastern Memorial Hospital | PubMed | ||
| 2023-C-124 | Far Eastern Memorial Hospital | PubMed | ||
| 2024-C-105 | Far Eastern Memorial Hospital | PubMed | ||
| 2025-C-093 | Far Eastern Memorial Hospital | PubMed | ||
| 2025-C-010 | Far Eastern Memorial Hospital | PubMed | ||
| FEMH-YZU-2023-027 | Yuan Ze University-FEMH Cooperation | PubMed |
Source PubMed
References100
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 36990212 | A single approach to targeting transferrin receptor 2 corrects iron and erythropoietic defects in murine models of anemia of inflammation and chronic kidney disease. | Kidney Int | 2023 | https://conductscience.org/library/papers/36990212 | PubMed |
| 2 | 38287134 | The multifaceted links between hearing loss and chronic kidney disease. | Nat Rev Nephrol | 2024 | https://conductscience.org/library/papers/38287134 | PubMed |
| 3 | 35351860 | Bone marrow mesenchymal stem cell-derived exosomal microRNA-381-3p alleviates vascular calcification in chronic kidney disease by targeting NFAT5. | Cell Death Dis | 2022 | https://conductscience.org/library/papers/35351860 | PubMed |
| 4 | 34176287 | Mesenchymal Stem/Stromal Cell-Derived Extracellular Vesicles for Chronic Kidney Disease: Are We There Yet? | Hypertension | 2021 | https://conductscience.org/library/papers/34176287 | PubMed |
| 5 | 38941462 | Netrin-1-engineered endothelial cell exosomes induce the formation of pre-regenerative niche to accelerate peripheral nerve repair. | Sci Adv | 2024 | https://conductscience.org/library/papers/38941462 | PubMed |
| 6 | 38965227 | Enhancing extracellular vesicle cargo loading and functional delivery by engineering protein-lipid interactions. | Nat Commun | 2024 | https://conductscience.org/library/papers/38965227 | PubMed |
| 7 | 38241148 | Notch receptor-ligand binding facilitates extracellular vesicle-mediated neuron-to-neuron communication. | Cell Rep | 2024 | https://conductscience.org/library/papers/38241148 | PubMed |
| 8 | 29182933 | MSC exosomes mediate cartilage repair by enhancing proliferation, attenuating apoptosis and modulating immune reactivity. | Biomaterials | 2018 | https://conductscience.org/library/papers/29182933 | PubMed |
| 9 | 36181766 | Efficacy of MSC in Patients with Severe COVID-19: Analysis of the Literature and a Case Study. | Stem Cells Transl Med | 2022 | https://conductscience.org/library/papers/36181766 | PubMed |
| 10 | 35356283 | Molecular Characterization of Differentiated-Resistance MSC Subclones by Single-Cell Transcriptomes. | Front Cell Dev Biol | 2022 | https://conductscience.org/library/papers/35356283 | PubMed |
| 11 | 18607390 | A critical role of IFNgamma in priming MSC-mediated suppression of T cell proliferation through up-regulation of B7-H1. | Cell Res | 2008 | https://conductscience.org/library/papers/18607390 | PubMed |
| 12 | 34783650 | Framework for rapid comparison of extracellular vesicle isolation methods. | Elife | 2021 | https://conductscience.org/library/papers/34783650 | PubMed |
| 13 | 35962195 | Isolation of mitochondria-derived mitovesicles and subpopulations of microvesicles and exosomes from brain tissues. | Nat Protoc | 2022 | https://conductscience.org/library/papers/35962195 | PubMed |
| 14 | 33864911 | Comparative study of commercial protocols for high recovery of high-purity mesenchymal stem cell-derived extracellular vesicle isolation and their efficient labeling with fluorescent dyes. | Nanomedicine | 2021 | https://conductscience.org/library/papers/33864911 | PubMed |
| 15 | 35180692 | Integrated microfluidic system for isolating exosome and analyzing protein marker PD-L1. | Biosens Bioelectron | 2022 | https://conductscience.org/library/papers/35180692 | PubMed |
| 16 | 34259095 | Preserving extracellular vesicles for biomedical applications: consideration of storage stability before and after isolation. | Drug Deliv | 2021 | https://conductscience.org/library/papers/34259095 | PubMed |
| 17 | 32324279 | How does temperature play a role in the storage of extracellular vesicles? | J Cell Physiol | 2020 | https://conductscience.org/library/papers/32324279 | PubMed |
| 18 | 24356509 | Sumoylated hnRNPA2B1 controls the sorting of miRNAs into exosomes through binding to specific motifs. | Nat Commun | 2013 | https://conductscience.org/library/papers/24356509 | PubMed |
| 19 | 37025062 | Extracellular vesicle-based delivery of silencing sequences for the treatment of Machado-Joseph disease/spinocerebellar ataxia type 3. | Mol Ther | 2023 | https://conductscience.org/library/papers/37025062 | PubMed |
| 20 | 22002097 | Nanochannel electroporation delivers precise amounts of biomolecules into living cells. | Nat Nanotechnol | 2011 | https://conductscience.org/library/papers/22002097 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 41971026 | Advancing mesenchymal stem cell therapy for kidney diseases in companion animals: from mechanisms to clinical application. | Front Vet Sci | 2026 | https://conductscience.org/library/papers/41971026 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41335159
GET https://conductscience.org/api/papers/v1/41335159/references?page=2